These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

154 related items for PubMed ID: 1501735

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Effects of recombinant human erythropoietin on renal function in chronic renal failure predialysis patients.
    Roth D, Smith RD, Schulman G, Steinman TI, Hatch FE, Rudnick MR, Sloand JA, Freedman BI, Williams WW, Shadur CA.
    Am J Kidney Dis; 1994 Nov; 24(5):777-84. PubMed ID: 7977319
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Effectiveness and safety of recombinant human erythropoietin (r-HuEPO) in the treatment of anemia of chronic renal failure in non dialysis patients. European Multicentre Study Group.
    Kulzer P, Schaefer RM, Krahn R, Schaefer L, Heidland A.
    Int J Artif Organs; 1994 Apr; 17(4):195-202. PubMed ID: 8070941
    [Abstract] [Full Text] [Related]

  • 8. Efficacy and tolerance of treatment with recombinant-human erythropoietin in chronic renal failure (pre-dialysis) patients.
    Frenken LA, Verberckmoes R, Michielsen P, Koene RA.
    Nephrol Dial Transplant; 1989 Apr; 4(9):782-6. PubMed ID: 2516609
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. The safety and the efficacy of maintenance therapy of recombinant human erythropoietin in patients with renal insufficiency.
    Lim VS, Kirchner PT, Fangman J, Richmond J, DeGowin RL.
    Am J Kidney Dis; 1989 Dec; 14(6):496-506. PubMed ID: 2596476
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Subcutaneous erythropoietin administration in predialysis patients: a single centre prospective study.
    Branger B, Vécina F, Zabadani B, Balducchi JP, Fourcade J.
    Nephrol Dial Transplant; 1995 Dec; 10 Suppl 6():36-9. PubMed ID: 8524492
    [Abstract] [Full Text] [Related]

  • 18. Correction of anaemia of chronic renal failure with recombinant human erythropoietin: safety and efficacy of one year's treatment in a European multicentre study of 150 haemodialysis-dependent patients.
    Sundal E, Kaeser U.
    Nephrol Dial Transplant; 1989 Dec; 4(11):979-87. PubMed ID: 2516891
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.